Biond Biologics

Developer of immunotherapies for oncology and autoimmune diseases

placeMisgav, Northern District, Israel calendar_todayFounded 2016 groups34 employees language biondbio.com

Social engagement

Social engagement: 2.7K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Harel Group, Israel Biotech Fund, Deep Insight.

Investor typeCountShare
Venture capital229%
Private equity229%
Other / undisclosed343%

Recent activity

22 Jun 2026
Milestone
regulatory
26 Apr 2026
Milestone
Biond Biologics
2 Sep 2025
Event
23rd Annual Global Healthcare Conference
Coming soon